Health & Safety Industry Today

PLI Pharmaceuticals Market 2018 - Current and Future Plans

Pune, India, 5th February 2018: WiseGuyReports announced addition of new report, titled “Partnerships, Licensing, Investments and M&A Deals and Trends for November 2017 in Pharmaceuticals”.
Published 05 February 2018
"Partnerships, Licensing, Investments and M&A Deals and Trends for November 2017 in Pharmaceuticals", report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture financing registered in the pharmaceuticals industry in November 2017. The report portrays detailed comparative data on the number of deals and their value in the last six months, subdivided by deal types, various therapy areas, and geographies. Additionally, the report provides information on the top financial advisory firms in the pharmaceuticals industry.
The pharmaceutical and healthcare industry reported a decrease in the number of deals and deal values in November 2017. The industry reported 375 deals worth USD26.8 billion in November 2017, compared to 444 deals worth USD32.3 billion in October 2017. The oncology therapeutics market remained at the top in deal activity in November 2017 with 110 deals. In second place, central nervous system therapeutics market reported 65 deals. Licensing agreements in pharmaceutical and healthcare industry registered an increase in upfront payments. The segment reported USD185.9m as upfront payments in November 2017, compared to USD57.4m in October 2017. The number of deals in North America a decreased to 219 in November 2017 from 298 in October 2017.
- Analysis of the market trends for the pharmaceutical industry in the global arena.
- Review of deal trends in the cardiovascular, central nervous system, dermatology, ear nose throat disorders, gastrointestinal, genito urinary system and sex hormones, hematological disorders, hormonal disorders, immunology, infectious disease, male health, metabolic disorders, mouth and dental disorders, musculoskeletal, oncology, ophthalmology, respiratory, toxicology, and women's health segments.
- Analysis of partnerships, licensing, M&As, equity/debt offerings, private equity, and venture financing deals in the pharmaceutical industry.
- Analysis of therapy areas which are very active in terms of venture capital financing, partnerships, licensing agreements, equity/debt offerings, and M&As.
- Analysis of deals based on different payment modes, including upfront and milestone payments, primarily in partnerships and licensing agreements in the pharmaceutical industry.
- Analysis of partnership and licensing deals based on clinical stage of development of products.
- Summary of the pharmaceutical deals globally in the six months.
- Information on the top deals happened in the pharmaceutical industry.
- Geographies covered include - North America, Europe, Asia Pacific, South & Central America, and the Middle East & Africa.
- League tables of financial advisors in M&As and equity/debt offerings. This includes key advisors such as Morgan Stanley, Credit Suisse, and Goldman Sachs.
Reasons to buy
- Enhance your decision making capability in a more rapid and time sensitive manner.
- Find out the major deal performing segments for investments in your industry.
- Evaluate the types of companies which are entering into partnership or licensing agreements; divesting and acquiring assets.
- Identify companies that are aggressively looking to raise capital in the market
- Evaluate niche therapy areas that are receiving majority of the upfront and milestone payments in the pharmaceutical industry.
- Identify the key venture capitalists, who are financing the pharmaceutical and biotech companies.
- Evaluate the clinical development stages where majority of the partnerships and licensing agreements are happening.
- Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the pharmaceutical industry.
- Identify growth segments and opportunities in each region within the industry.
- Look for key financial advisors where you are planning to raise capital from the market or for acquisitions within the industry.
Table of Content: Key Points
1 Table of Contents 2
    1.1 List of Tables 5
    1.2 List of Figures 7
2 Pharmaceuticals & Healthcare, Global, Deal Summary 10
    2.1 Pharmaceuticals & Healthcare, Global, Deal Analysis, November 2017 10
    2.2 Pharmaceuticals & Healthcare, Global, Major Deals, November 2017 11
      2.2.1 Anthem Raises USD5.5 Billion in Private Placement of Notes 12
      2.2.2 Janssen Biotech Enters into Licensing Agreement with Zymeworks 12
      2.2.3 Shanghai Pharma to Acquire China Business from Cardinal Health for USD1.2 Billion 12
      2.2.4 Bayer and PeptiDream Enter into Partnership 12
      2.2.5 Bayer Enters into Co-Development Agreement with Loxo Oncology 13
    2.3 Pharmaceuticals & Healthcare, Global, by Type, Number of Deals, November 2017 14
    2.4 Pharmaceuticals & Healthcare, Global, by Type, Deal Values, November 2017 15
3 Pharmaceuticals and Healthcare, Global, Deals, Summary, by Type 16
    3.1 Pharmaceuticals & Healthcare, Global, M&A, November 2017 16
      3.1.1 Top M&A Deals in November 2017 17
      3.1.2 Pharmaceuticals & Healthcare, Global, M&A Deals by Therapy Area, June 2017 - November 2017 18
    3.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, November 2017 19
      3.2.1 Top Equity Offering Deals in November 2017 20
      3.2.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals by Therapy Area, June 2017 - November 2017 21
    3.3 Pharmaceuticals & Healthcare, Global, Private Equity and Venture Capital Deals, November 2017 22
      3.3.1 Top PE/VC Deals in November 2017 23
      3.3.2 Pharmaceuticals & Healthcare, Global, PE/VC by Therapy Area, November 2017 24
      3.3.3 Pharmaceuticals & Healthcare, Global, Venture Capital Deals by Stage of Financing, November 2017 25
ACCESS REPORT @             
Contact Info:                                                         
NORAH TRENT                                                          
Ph: +1-646-845-9349 (US)                          
Ph: +44 208 133 9349 (UK)                                                   
Get in touch:                                                         

Other Industry News

Ready to start publishing

Sign Up today!